Key result
A combination of dexmedetomidine and remifentanil effectively interrupted the release of catecholamines and minimized hemodynamic fluctuations during the resection of pheochromocytoma in an adolescent.
Why the study?
Does the combination of dexmedetomidine and remifentanil provide hemodynamic stability and control catecholamine release during pheochromocytoma resection in an adolescent?
Case Report (n=1)
No
Does the combination of dexmedetomidine and remifentanil provide hemodynamic stability and control catecholamine release during pheochromocytoma resection in an adolescent?
The combination of dexmedetomidine and remifentanil may help interrupt catecholamine release and minimize hemodynamic fluctuations during pheochromocytoma resection, though additional vasodilators may still be required during tumor manipulation.
May support hemodynamic stability with dexmedetomidine-remifentanil in adolescent pheochromocytoma resection; hypothesis-generating, needs prospective confirmation.
A 15-year-old adolescent with unilateral multiple adrenal pheochromocytoma had an episode of subcortical intracerebral hemorrhage and seizure 6 weeks before the surgery. He was pretreated with terazosin, losartan, atenolol and levetiracetam for 2 weeks. Dexmedetomidine was started in the preoperative waiting area, and a combination of dexmedetomidine and remifentanil was continuously infused for most of anesthetic time. To control blood pressure, bolus injection of remifentanil and low-dose infusion of sodium nitroprusside, nicardipine, and esmolol were administered during three adrenergic crises. There was minimal post-resection hypotension, and his trachea was extubated safely 20 min after the surgery. He was discharged without noticeable complication. His catecholamine levels showed the steadily decreasing pattern during the operation in this case. Though a combination of dexmedetomidine and remifentanil may not prevent the hemodynamic instability impeccably during the tumor manipulation, this combination seems to be the way of interrupting release of catecholamines and minimizing hemodynamic fluctuations.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2012) conducted a case report in Pheochromocytoma (n=1). Dexmedetomidine and remifentanil was evaluated on Hemodynamic stability and catecholamine levels. A combination of dexmedetomidine and remifentanil effectively interrupted the release of catecholamines and minimized hemodynamic fluctuations during the resection of pheochromocytoma in an adolescent.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: